PLUS1
39.5007
-2.85 (-6.73%)
-2.85 (-6.73%)
Upgrade to Real-Time
Afterhours
| Volume | 1,997,827 |
|
|||||
| News | - | ||||||
| Day High | 42.7599 | Low High |
|||||
| Day Low | 39.1408 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cassava Sciences Inc | SAVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -2.85 | -6.73% | 39.5007 | 16:04:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 42.02 | 39.1408 | 42.7599 | 39.93 | 42.35 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 19,613 | 1,997,827 | $ 40.67 | $ 81,249,630 | - | 13.84 - 100.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:05:55 | 11 | $ 39.85 | USD |
Period:
Draw Mode:
Cassava Sciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.58B | 40.10M | 37.85M | $ - | $ - | -0.82 | -27.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 141.16k | 5.20% |
Cassava Sciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SAVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 42.63 | 46.29 | 39.1408 | 41.89 | 2,046,602 | -3.13 | -7.34% |
| 1 Month | 30.08 | 51.59 | 29.39 | 42.83 | 4,769,878 | 9.42 | 31.32% |
| 3 Months | 23.78 | 51.59 | 13.84 | 31.67 | 3,924,672 | 15.72 | 66.11% |
| 6 Months | 28.95 | 51.59 | 13.84 | 29.53 | 2,605,819 | 10.55 | 36.44% |
| 1 Year | 52.94 | 100.00 | 13.84 | 43.14 | 2,939,603 | -13.44 | -25.39% |
| 3 Years | 1.24 | 146.16 | 1.05 | 35.80 | 4,056,639 | 38.26 | 3,085.54% |
| 5 Years | 1.21 | 146.16 | 1.00 | 35.49 | 3,490,388 | 38.29 | 3,164.52% |
Cassava Sciences Description
| Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. |
